Conatumumab 返回列表页

仅用于工业应用或科学研究，不可用于人类或动物的临床诊断或治疗，非药用. Conatumumab （AMG 655） is a human monoclonal agonist antibody against human death receptor 5 （DR5, TRAILR2） （Kd: 1 nM for the long form of DR5, 0.8 nM for the short form of DR5）. Conatumumab induces apoptosis via caspase activation. Conatumumab can be used in the research of cancers